Elite Pharmaceuticals Inc (ELTP)

[Just give me $1.50]

That's actually bad news given Nasrat's track record when he's confident.

-SequestOx failure ("SequestOx IS coming to the market.")
-Adderall XR 8-10 month approval delay (Didn't do one of the required test)
-$75,000 to re-due the ENTIRE shareholder meeting vote 6 months later (Total embarrassment)
-"We WILL be on the Nasdaq in 2019 and we WILL be in dollarland at that time" (Lol)
-"Methotrexate WILL be approved by the February 2024 GDUFA date" (3-month delay)
-2 ANDA filings in 2024 (Not even BE studies yet)

etc, etc, etc...

NH seems to be very confident…..that speaks volumes.